Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA
Menopause. 2013 20 (3): 354-8

PMID: 23435034 · PMCID: PMC3549049 · DOI:10.1097/GME.0b013e318268ca46

MeSH Terms (19)

Alleles Breast Neoplasms Case-Control Studies DNA Estrogen Replacement Therapy Estrogens Female Genetic Predisposition to Disease Genome-Wide Association Study Genotype Humans Middle Aged Odds Ratio Polymorphism, Single Nucleotide Postmenopause Progestins Receptor, Fibroblast Growth Factor, Type 2 Risk Factors United States

Connections (2)

This publication is referenced by other Labnodes entities: